The COVID-19 pandemic has created challenges across the entirety of the medical landscape. Oncologists and hematologists are just a few of many healthcare providers (HCPs) that have had to adjust to these challenges on the fly.
Dave Heckard, Brand Insights Contributor, EVP, Healthcare Research & Analytics (HRA®)
Advertisement
Articles by Dave Heckard, Brand Insights Contributor, EVP, Healthcare Research & Analytics (HRA®)
Advertisement
Latest Updated Articles
- How Oncologists Cope with COVID-19
Published: July 15th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: AbbVie Advances its Pipeline
2
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
3
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
4
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
5